Retatrutide works as a triple agonist, hitting GLP-1, GIP, and glucagon receptors all at once. Semaglutide only targets GLP-1, tirzepatide covers GLP-1 and GIP. That glucagon piece is the added ingredient unique to retatrutide, and it's mechanistically what drives the potential body composition...